RVL Pharmaceuticals plc Proceeds from Fees Received
RVL Pharmaceuticals plc reported Proceeds from Fees Received of $914.00 thousand for the 12-month period ending 2022-12-31, per its 10-K filed 2023-03-20.
Discontinued › Cash Flow › Financing Activities
us-gaap:ProceedsFromFeesReceived · last filed 2023-03-20
- RVL Pharmaceuticals plc proceeds from fees received for the quarter ending 2022-12-31 was $0.00.
- RVL Pharmaceuticals plc proceeds from fees received for fiscal 2022 was $914.00K, a 72.35% decline from fiscal 2021.
- RVL Pharmaceuticals plc proceeds from fees received for fiscal 2021 was $3.31M.
| Period end | Proceeds from Fees Received 3 month | Proceeds from Fees Received 9 month | Proceeds from Fees Received 12 month |
|---|---|---|---|
| 2022-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-20 | $914.00K 10-K · filed 2023-03-20 | |
| 2022-09-30 | $914.00K 10-Q · filed 2022-11-10 | ||
| 2021-12-31 | $3.31M 10-K · filed 2023-03-20 |